Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29.
D000499:Allylamine / Q000031:analogs & derivatives*; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D001491:Basophils / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008407:Mast Cells / Q000187:drug effects; D008614:Meperidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D000701:Analgesics, Opioid; D002082:Butylamines; D010276:Parasympatholytics; D000499:Allylamine; D009020:Morphine; D008614:Meperidine; C029665:N,N-dimethyl-3,3-diphenyl-1-methylallylamine; C012394:ketobemidone